Skip to main content
Erschienen in: Familial Cancer 3/2007

01.09.2007

Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study

verfasst von: Michelle N. Harvie, Saba Bokhari, Andrew Shenton, Linda Ashcroft, Gareth Evans, Ric Swindell, Anthony Howell

Erschienen in: Familial Cancer | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Adult weight gain and central obesity can increase breast cancer risk. We determined the prevalence of adult weight gain and central obesity amongst women with a family history (FH) as compared to women with a population risk to determine whether adiposity could contribute to their increased risk. Adult weight gain, waist and waist:hip ratio (WHR) were determined amongst 475 women (aged 20–60 years) attending a regional FH breast cancer risk clinic, compared to 312 age matched women at population risk. Patterns of adult weight gain did not differ between women with and without a FH of breast cancer. The majority of weight gain occurred between the ages of 20 and 40 in both groups. Mean (sd) weight gain for women aged >40 years with a FH was 8.9 (10.3) kg compared to 9.1 (10.6) kg for controls (p = 0.85). Women with a FH had a significantly greater waist and WHR than controls. Mean (sd) waist was 83.7 (13) cm compared to 81.6 (11.3) cm for controls (p < 0.01). Mean (sd) WHR was 0.82 (0.1) compared to 0.80 (0.1) for controls (p < 0.01). FH of breast cancer was an independent predictor of having a WHR of >0.85; odds ratio (95% CI) = 1.42 (1.01–2.01) (p = 0.044). Significant weight gain between the ages of 20 and 40 and the prevalence of central obesity amongst FH women suggest the need for weight management within FH clinics.
Literatur
1.
Zurück zum Zitat Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407–1411PubMedCrossRef Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407–1411PubMedCrossRef
2.
Zurück zum Zitat Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE (2004) Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 13:220–224PubMedCrossRef Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE (2004) Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 13:220–224PubMedCrossRef
3.
Zurück zum Zitat Harvie M, Hooper L, Howell AH (2003) Central obesity and breast cancer risk: a systematic review. Obes Rev 4:157–173PubMedCrossRef Harvie M, Hooper L, Howell AH (2003) Central obesity and breast cancer risk: a systematic review. Obes Rev 4:157–173PubMedCrossRef
4.
Zurück zum Zitat Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, Berrino F, Tjonneland A, Bigaard J, Olsen A, Overvad K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D, Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C, Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Amiano P, Pera G, Quiros JR, Martinez C, Tormo MJ, Wirfalt E, Berglund G, Hallmans G, Key TJ, Reeves G, Bingham S, Norat T, Biessy C, Kaaks R, Riboli E (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 111:762–771PubMedCrossRef Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, Berrino F, Tjonneland A, Bigaard J, Olsen A, Overvad K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D, Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C, Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Amiano P, Pera G, Quiros JR, Martinez C, Tormo MJ, Wirfalt E, Berglund G, Hallmans G, Key TJ, Reeves G, Bingham S, Norat T, Biessy C, Kaaks R, Riboli E (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 111:762–771PubMedCrossRef
5.
Zurück zum Zitat Magnusson C, Colditz G, Rosner B, Bergstrom R, Persson I (1998) Association of family history and other risk factors with breast cancer risk (Sweden). Cancer Causes Control 9:259–267PubMedCrossRef Magnusson C, Colditz G, Rosner B, Bergstrom R, Persson I (1998) Association of family history and other risk factors with breast cancer risk (Sweden). Cancer Causes Control 9:259–267PubMedCrossRef
6.
Zurück zum Zitat Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A, Longnecker MP, Mittendorf R, Greenberg ER, Willett WC (1998) Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev 7:359–364PubMed Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A, Longnecker MP, Mittendorf R, Greenberg ER, Willett WC (1998) Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev 7:359–364PubMed
7.
Zurück zum Zitat Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE (1999) Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol 150:1316–1324PubMed Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE (1999) Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol 150:1316–1324PubMed
8.
Zurück zum Zitat Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L (2003) Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 106:96–102PubMedCrossRef Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L (2003) Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 106:96–102PubMedCrossRef
9.
Zurück zum Zitat Sellers TA, Davis J, Cerhan JR, Vierkant RA, Olson JE, Pankratz VS, Potter JD, Folsom AR (2002) Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol 155:225–233PubMedCrossRef Sellers TA, Davis J, Cerhan JR, Vierkant RA, Olson JE, Pankratz VS, Potter JD, Folsom AR (2002) Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol 155:225–233PubMedCrossRef
10.
Zurück zum Zitat Hirose K, Tajima K, Hamajima N, Takezaki T, Inoue M, Kuroishi T, Miura S, Tokudome S (2001) Association of family history and other risk factors with breast cancer risk among Japanese premenopausal and postmenopausal women. Cancer Causes Control 12:349–358PubMedCrossRef Hirose K, Tajima K, Hamajima N, Takezaki T, Inoue M, Kuroishi T, Miura S, Tokudome S (2001) Association of family history and other risk factors with breast cancer risk among Japanese premenopausal and postmenopausal women. Cancer Causes Control 12:349–358PubMedCrossRef
11.
Zurück zum Zitat Taioli E, Wynder EL (1992) Family history, body-fat distribution, and the risk of breast cancer. N Engl J Med 327:958–959PubMedCrossRef Taioli E, Wynder EL (1992) Family history, body-fat distribution, and the risk of breast cancer. N Engl J Med 327:958–959PubMedCrossRef
12.
Zurück zum Zitat Seiddell J (1991) Waist/hip and waist/thigh ratios. In: Fidanza F (ed) Nutritional status assessment. Chapman & Hall, London, pp 24–29 Seiddell J (1991) Waist/hip and waist/thigh ratios. In: Fidanza F (ed) Nutritional status assessment. Chapman & Hall, London, pp 24–29
13.
Zurück zum Zitat Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S (1989) The predictive validity of body mass index based on self-reported weight and height. Int J Obes 13:441–453PubMed Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S (1989) The predictive validity of body mass index based on self-reported weight and height. Int J Obes 13:441–453PubMed
14.
Zurück zum Zitat Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ (1988) Accuracy and reliability of self-measurement of body girths. Am J Epidemiol 128:740–748PubMed Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ (1988) Accuracy and reliability of self-measurement of body girths. Am J Epidemiol 128:740–748PubMed
15.
Zurück zum Zitat WHO, NUT, NCD (1997) Obesity. Preventing and managing the global epidemic. Report of WHO consultation on obesity 3–5 June 1997, 98, 1. WHO, Geneva WHO, NUT, NCD (1997) Obesity. Preventing and managing the global epidemic. Report of WHO consultation on obesity 3–5 June 1997, 98, 1. WHO, Geneva
16.
Zurück zum Zitat Rose KM, Newman B, Mayer-Davis EJ, Selby JV (1998) Genetic and behavioral determinants of waist–hip ratio and waist circumference in women twins. Obes Res 6:383–392PubMed Rose KM, Newman B, Mayer-Davis EJ, Selby JV (1998) Genetic and behavioral determinants of waist–hip ratio and waist circumference in women twins. Obes Res 6:383–392PubMed
17.
Zurück zum Zitat Olson JE, Atwood LD, Grabrick DM, Vachon CM, Sellers TA (2001) Evidence for a major gene influence on abdominal fat distribution: the Minnesota Breast Cancer Family Study. Genet Epidemiol 20:458–478PubMedCrossRef Olson JE, Atwood LD, Grabrick DM, Vachon CM, Sellers TA (2001) Evidence for a major gene influence on abdominal fat distribution: the Minnesota Breast Cancer Family Study. Genet Epidemiol 20:458–478PubMedCrossRef
18.
Zurück zum Zitat Jernstrom HC, Olsson H, Borg A (1997) Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19–25 years who were first and/or second degree relatives to breast cancer patients. Eur J Cancer Prev 6:330–340PubMedCrossRef Jernstrom HC, Olsson H, Borg A (1997) Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19–25 years who were first and/or second degree relatives to breast cancer patients. Eur J Cancer Prev 6:330–340PubMedCrossRef
19.
Zurück zum Zitat Schapira DV, Kumar NB, Lyman GH (1993) Variation in body fat distribution and breast cancer risk in the families of patients with breast cancer and control families. Cancer 71:2764–2768PubMedCrossRef Schapira DV, Kumar NB, Lyman GH (1993) Variation in body fat distribution and breast cancer risk in the families of patients with breast cancer and control families. Cancer 71:2764–2768PubMedCrossRef
20.
Zurück zum Zitat Baghaei F, Rosmond R, Westberg L, Hellstrand M, Eriksson E, Holm G, Bjorntorp P (2003) The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res 11:578–585PubMedCrossRef Baghaei F, Rosmond R, Westberg L, Hellstrand M, Eriksson E, Holm G, Bjorntorp P (2003) The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res 11:578–585PubMedCrossRef
21.
Zurück zum Zitat van Rossum EF, Voorhoeve PG, te Velde SJ, Koper JW, Delemarre-van de Waal HA, Kemper HC, Lamberts SW (2004) The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J Clin Endocrinol Metab 89:4004–4009PubMedCrossRef van Rossum EF, Voorhoeve PG, te Velde SJ, Koper JW, Delemarre-van de Waal HA, Kemper HC, Lamberts SW (2004) The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J Clin Endocrinol Metab 89:4004–4009PubMedCrossRef
22.
Zurück zum Zitat Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H (2003) Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord 27:1020–1027PubMedCrossRef Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H (2003) Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord 27:1020–1027PubMedCrossRef
23.
Zurück zum Zitat Curran JE, Lea RA, Rutherford S, Weinstein SR, Griffiths LR (2001) Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer 95:271–275PubMedCrossRef Curran JE, Lea RA, Rutherford S, Weinstein SR, Griffiths LR (2001) Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer 95:271–275PubMedCrossRef
24.
Zurück zum Zitat Haiman CA, Hankinson SE, Spiegelman D, De VI, Colditz GA, Willett WC, Speizer FE, Hunter DJ (2000) A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer 87:204–210PubMedCrossRef Haiman CA, Hankinson SE, Spiegelman D, De VI, Colditz GA, Willett WC, Speizer FE, Hunter DJ (2000) A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer 87:204–210PubMedCrossRef
25.
Zurück zum Zitat Peto J, Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26:411–414PubMedCrossRef Peto J, Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26:411–414PubMedCrossRef
26.
Zurück zum Zitat Meijers-Heijboer H, van den OA, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59PubMedCrossRef Meijers-Heijboer H, van den OA, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59PubMedCrossRef
27.
Zurück zum Zitat Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE (1999) Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol 150:1316–1324PubMed Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE (1999) Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol 150:1316–1324PubMed
28.
Zurück zum Zitat Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA (2003) Waist circumference, waist–hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 254:555–563PubMedCrossRef Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA (2003) Waist circumference, waist–hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 254:555–563PubMedCrossRef
29.
Zurück zum Zitat Department of Health (2003) Health survey England risk factors for cardiovascular disease, vol 2. http://www.dh.gov.uk/assetRoot/04/09/89/11/04098911.pdf Department of Health (2003) Health survey England risk factors for cardiovascular disease, vol 2. http://​www.​dh.​gov.​uk/​assetRoot/​04/​09/​89/​11/​04098911.​pdf
30.
Zurück zum Zitat Ziebland S, Robertson J, Jay J, Neil A (2002) Body image and weight change in middle age: a qualitative study. Int J Obes Relat Metab Disord 26:1083–1091PubMedCrossRef Ziebland S, Robertson J, Jay J, Neil A (2002) Body image and weight change in middle age: a qualitative study. Int J Obes Relat Metab Disord 26:1083–1091PubMedCrossRef
31.
Zurück zum Zitat Hopwood P, Shenton A, Lalloo F, Evans DG, Howell A (2001) Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 38:139PubMedCrossRef Hopwood P, Shenton A, Lalloo F, Evans DG, Howell A (2001) Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 38:139PubMedCrossRef
32.
Zurück zum Zitat Bigaard J, Spanggaard I, Thomsen BL, Overvad K, Tjonneland A (2005) Self-reported and technician-measured waist circumferences differ in middle-aged men and women. J Nutr 135:2263–2270PubMed Bigaard J, Spanggaard I, Thomsen BL, Overvad K, Tjonneland A (2005) Self-reported and technician-measured waist circumferences differ in middle-aged men and women. J Nutr 135:2263–2270PubMed
Metadaten
Titel
Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study
verfasst von
Michelle N. Harvie
Saba Bokhari
Andrew Shenton
Linda Ashcroft
Gareth Evans
Ric Swindell
Anthony Howell
Publikationsdatum
01.09.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Familial Cancer / Ausgabe 3/2007
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-007-9122-3

Weitere Artikel der Ausgabe 3/2007

Familial Cancer 3/2007 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.